ArticlePeerJ2026
Validity and reliability evaluation of the Chinese version of the attention-deficit/hyperactivity disorder stigma questionnaire.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Psychological problems among children and adolescents are increasing, and people with attention-deficit/hyperactivity disorder (ADHD) face varying degrees of stigma as they grow up. Such perceptions of stigma can prevent them from seeking psychological help and adhering to treatment. However, a standardized instrument for assessing ADHD-related stigma in Chinese populations is lacking. This study assessed the validity and reliability of a Chinese version of the Attention-Deficit/Hyperactivity Disorder Stigma Questionnaire (ASQ). Methods: A total of 508 adolescents with ADHD, mostly aged 11-13 years (mean age = 13.68 ± 2.12 years), participated in this study. Among them, 51.8% were junior high school students, and the distribution of male and female participants was relatively balanced. Data were collected from two Chinese hospitals between September 2023 and September 2024. The ASQ was translated and culturally adapted into Simplified Chinese. Psychometric evaluation included exploratory and confirmatory factor analyses, assessment of internal consistency, test-retest reliability, and examination of content and construct validity. Results: Confirmatory factor analysis supported a three-factor structure for the study, demonstrating good model fit ( Conclusions: The Chinese version of the ASQ is a valid and reliable measurement tool that can be used for assessing ADHD-related stigma in Chinese adolescents. This survey tool can assist healthcare professionals in this field in identifying and addressing stigma more effectively, thereby improving treatment adherence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.